Trial Acronym | STAR Aspirin |
Clinical Area | Critical Care |
Description | An ICU based clinical trial to test the hypothesis that aspirin is safe and improves important surrogate clinical outcomes in adult patients with ARDS. |
Status | Closed |
Date Opened to Recruitment | |
Target Recruitment | 60 |
Recruitment to date | 30 |
Date Closed to Recruitment | 25/11/2018 |
No. of Sites | 4 |
Trial Design | A prospective, randomised, double-blind, allocation concealed, placebo-controlled phase 2, clinical trial in patients with ARDS. |
Study Aim | The aim of this study is to test the hypothesis that aspirin is safe and improves important surrogate clinical outcomes in adult patients with ARDS.
Objective 1: To conduct a randomised, double-blind, allocation concealed, placebo-controlled phase 2 trial of aspirin as a treatment for ARDS. |
Chief Investigator | Professor Danny McAuley |
Sponsors | BHSCT |
Funder | The Health & Social Care Research & Development Division of the Public Health Agency, Northern Ireland. |